focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

Share Price Information for Brand Architek. (BAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 26.00
Ask: 29.00
Change: 0.10 (0.36%)
Spread: 3.00 (11.538%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.40
BAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

2 Mar 2015 07:00

RNS Number : 1320G
Swallowfield PLC
02 March 2015
 

Swallowfield plc

("Swallowfield" or the "Group")

 

Interim Results

 

Swallowfield, a market leader in the development, formulation, and supply of personal care and beauty products; whose customers include many of the world's leading brands, announces its interim results for the 28 weeks ended 10 January 2015

 

2015

2014

Revenue

£26.0m

£25.4m

Revenue (constant currency) ¹

£26.6m

£25.4m

Operating profit

£0.16m

£0.13m

Profit / (loss) before tax

£0.06m

£(0.02)m

Basic and diluted earnings per share

0.4p

0.3p

Net debt

£3.1m

£4.6m

 

¹ Revenue translated at 2014 exchange rates

 

HEADLINES

· Profitability increased in the period with an operating profit of £0.16m (2014: £0.13m) and a return to modest profitability on a profit before tax basis.

· Revenue growth of 2.1% at £26.0m (2014: £25.4m) with 8% growth from our 'drive' product categories. Revenues were 4.4% higher than prior year on a constant currency basis.

· Continued strong performance in our export markets with non-UK sales growing 12% and direct exports now representing 39% of revenue (2014: 35%).

· Cost optimisation project was completed as planned at our Bideford site.

· Tight control of costs and working capital has reduced net debt to £3.1m (2014: £4.6m).

· A number of brand launches scheduled in the second half expected to positively impact future performance.

· First production of innovative new plastic aerosol technology. This innovation represents a world first in its product category and format (i.e. a bag on valve aerosol product in a plastic container) which offers the consumer significant benefits.

 

Brendan Hynes, Non-executive Chairman, commented:

 

"The first half year profitability is in line with our expectations and we are making good, underlying progress with our new, "building a better Swallowfield" strategy. We are investing for the future, repositioning the business and delivering industry leading, innovative new products and packaging formats. This strategy will continue to strengthen our market position and help to build shareholder value in both the medium and long term."

 

Chris How, Chief Executive, commented:

 

"We are pleased with a solid first half performance, with continuing improvement in sales, margin and cash generation. Having stabilised the base business performance we have been able to make good progress on a number of the key strategic pillars with incremental profit streams starting to benefit the second-half year."

 

 

For further information please contact:

Swallowfield plc

Chris How

Chief Executive Officer

01823 662 241

Mark Warren

Group Finance Director

01823 662 241

 

Jonny Franklin-Adams/Jen Boorer

N+1 Singer

0207 496 3000

Alan Bulmer

Investor Focus International

07831 654744

Chris Lawrance

JBP Public Relations

0117 907 3400

 

 

Business Review

 

Revenue showed growth of 2.1% at £26.0m (2014: £25.4m); strong export growth of 12%, with direct export now representing 39% of turnover, offsetting some weakness in the UK market performance. The weakness of the Euro has reduced sales revenue by £0.6m, so revenue growth on a constant currency basis would have been 4.4%.

 

Direct contribution margins - defined as net sales less materials, direct labour, and other direct costs - increased by 0.4 percentage points compared with the same period last year. This reflects cost reduction efforts, the broadening of the customer base, and continued focus on new product development, all mitigating the negative impact of the weakened Euro.

 

We have continued to reduce our dependency on certain clients, the broadening of our overall customer and geographic mix, plus the product category focus, has further improved our risk profile.

 

Key innovation and in-house brand projects progressed well during the period:

 

In collaboration with one of our largest customers, Swallowfield has successfully developed and produced an aerosolised post-foaming shower gel in a plastic 'can'. Production commenced in December and is now appearing in stores across the UK. This innovation represents a world first in its product category and format i.e. a bag on valve aerosol product in a plastic container which offers significant benefits to the consumer.

 

Further, we received initial orders for our first Swallowfield owned brand which will appear in value retail channels imminently. Furthermore we have begun discussions with major national department store retailers regarding the distribution of our new premium beauty brand which will begin production in March.

 

These initiatives have resulted in a modest level of overhead investment in key personnel and skills to extend our capabilities.

 

The previously identified cost savings related to the re-organisation of our Bideford site have been delivered and we continue to focus on further opportunities with several active projects underway.

 

The net effect is that the Group made an operating profit of £0.16m (2014: £0.13m). Profit before tax returned to modest profitability of £0.06m (2014: loss of £0.02m). The net tax charge reflects the tax charge in the Czech Republic and a tax credit in the UK, resulting in an adjusted earnings per share of 0.4p (2014: 0.3p).

 

The Group's Chinese strategic investment of a 19% shareholding in Shanghai Colour Cosmetics Technology Company Limited (SCCTC) was re-valued during the period to fair value based on SCCTC's 31 December 2014 net assets. The initial cost of this investment was £0.14m and this is now valued at £0.38m in addition to the £0.1m of dividend income received since acquisition.

 

Net Debt and Cash Flow

 

Net debt decreased from a year-end position of £5.1m to £3.1m (2014: £4.6m). We have continued our focus on working capital with good results achieved. The net debt at the half year is generally lower than at the full year, and with the brand launches in the second-half we anticipate an increased investment in the second half of this financial year.

 

Financing costs of £0.11m (2014: £0.15m) comprised interest expense of £0.06m (2014: £0.07m) plus a pension scheme finance charge of £0.05m (2014: charge £0.08m).

 

Capital expenditure was £0.8m which was £0.3m above depreciation. We expect capital expenditure to be higher than depreciation in this financial year due to the timing of a major aerosol capital project straddling the year-end June 2014 date, the investment in our cost base optimisation project at Bideford, and investment in our new product development projects.

 

 

 

Dividends

 

The business is now progressing a number of strategic opportunities which are designed to build shareholder value in the medium and long term. These will require investment both in working capital and brand marketing / promotional support. Through this period of investment the dividend policy is expected to be relatively conservative.

 

No interim dividend has therefore been proposed.

 

Looking forward, it is the directors' intention to reinstate a dividend and to align the level of dividend payment to the underlying earnings and cash flow of the business. The dividend will be set taking into account the level of gearing and the operational requirements of the business.

 

Defined Benefit Pension Scheme

 

The Group operates a defined benefit scheme. For accounting purposes at 10 January 2015, the Group recognised under IAS19 'employee benefits', a deficit of £5.0m (30 June 2014: £2.2m); The Accounting Standards require the discount rate to be based on yields on high quality (usually AA-rated) corporate bonds of appropriate currency, taking into account the term of the relevant pension scheme's liabilities. Corporate bond indices are used as a proxy to determine the discount rate. At the reporting date, the yields on bonds of all types were significantly lower than they were at 30 June 2014. This has resulted in lower discount rates being adopted for accounting purposes compared to last year, offset by a reduction in expectations of long term inflation, and this has translated into significantly higher liabilities.

 

The defined benefit pension scheme is currently undergoing its latest triennial valuation as of 5 April 2014 the results of which are expected to be finalised by the end of the current financial year.

 

Progress vs Strategy

 

'Creating for Tomorrow, Delivering for Today'

 

Our business strategy is developed on two complimentary platforms. The first 'Creating for Tomorrow' identifies the strategic pillars that we believe will help us create a stronger business in the mid and long term. The second 'Delivering for Today' identifies some key operational focus areas that we need to drive in order to deliver our more immediate (i.e. current fiscal) performance.

 

The 4 strategic pillars of 'Creating for Tomorrow' are:

 

Product Category Focus

The business is focussing on a select number of 'drive' product categories where Swallowfield has an existing and sustainable competitive advantage. Future investment of both human and financial resources will be prioritised to drive higher growth and profitability in each of these categories.

 

Our drive categories include - personal care aerosols; hot pour products (such as lip balms and deodorant sticks) and anti-perspirant roll-ons. We are pleased to report that our first half sales growth in our drive categories was 8%.

 

New Product Development

We are utilising our product development, manufacturing, and distribution expertise to create innovative ranges of products, which will be taken to market under our own brand names. These will be positioned to avoid any direct conflict with our existing valued customer base.

 

We are pleased to have taken our first trade orders in H1 for the first one of our 'value' brands, 'Tru Shave', and have entered into discussion with national department stores on our first premium beauty brand, 'Bagsy'. Trade reaction to date for 'Bagsy' has been very positive, however the retailer decision making and ranging process takes time and, as a result, our projected sales and margin delivery may take a few months longer than originally anticipated thereby pushing some of the benefits into the next financial year.

 

We are continuing to evaluate opportunities to accelerate our strategy delivery in this area, and create accretive growth, including possible acquisitions.

 

Following the first sales of our innovative new plastic aerosol product in a post-foaming shower gel format, we will now seek to extend this technology to other 'drive' product categories and customers.

The technology offers the consumer and brand owners' significant benefits:

 

· Soft to touch

· Warm to touch

· Greater flexibility in 'can' shapes due to plastic moulding capability

· Lighter in use and transportation (packaging weight is 18 % lighter than previous metal format)

· Less likely to cause damage if dropped

· Corrosion resistant in a bathroom environment

· Packaging and design consistency with other products in a brand range likely to be in plastic bottles, tubes, jars etc…

 

This project, which has created a world-first product, has taken three years to develop and included many technical innovations to overcome challenges around elements such as: pressurisation precision, crimping technology, gassing techniques, formulation compatibility, shrink-sleeving onto heat sensitive PET and many more.

 

Emerging New Category

Our objective is to develop a capability in a new high growth, high margin product category that can become an additional 'drive' category by 2016. In H1 we have run production trials on aerosolised food and beverage products and expect to run production trials for another new product category in the second half. We will continue to evaluate the respective options with a view to scaling up in FY16.

 

Cost Base Optimisation

We aim to improve our asset utilisation across our locations, which will reduce the cost base and improve productivity. As an example we have now consolidated our Bideford site into two buildings from three, relocating selected manufacturing lines to Tabor in the Czech Republic. This project was completed in the first half and will deliver full year savings of £0.23m. We are continuing to evaluate options to optimise the use and location of our production assets across all Group sites.

 

Outlook

 

The UK and European market place remains extremely competitive, with pressure on pricing and continuing uncertainty around the Euro. The second half year performance remains dependent on the exact timing of planned product launches, the impact of wider economic conditions and underlying consumer demand.

 

Overall for the current year we expect to report strong PBT growth versus prior year, as more of our new product developments reach the market over the coming months. In terms of run rate profitability, we expect a more significant full year benefit to be delivered next year.

 

We continue to build positive momentum with the outlined strategy with underlying sales growth being achieved, and further new products and brand launches expected in the second half of this year. This will continue to underpin revenue and profitability growth and help to build shareholder value in the medium and longer term.

Group Statement of Comprehensive Income

 

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

Continuing operations

Notes

£'000

£'000

£'000

Revenue

2

25,975

25,432

50,033

Cost of sales

(23,321)

(23,012)

(44,859)

Gross profit

2,654

2,420

5,174

Commercial and administrative costs

(2,490)

(2,294)

(4,406)

Operating profit before exceptional items

164

126

768

Exceptional items

2

-

-

(366)

Operating profit / (loss)

Finance income

 

3

164

-

126

-

402

16

Finance costs

3

(108)

(150)

(278)

Profit / (loss) before taxation

56

(24)

140

Taxation

(7)

60

17

Profit after taxation

 

49

36

157

Other comprehensive (loss) / income for the period:

Re-measurement of defined benefit liability

7

(2,142)

(54)

608

Items that will be reclassified subsequently to profit or loss

Exchange differences on translating foreign operations

(54)

(128)

(167)

Gain / (loss) on available for sale financial assets

63

(53)

(47)

Other comprehensive (loss) / income for the period

(2,133)

(235)

394

Total comprehensive (loss) / income for the period

 

(2,084)

 

(199)

 

551

Profit attributable to:

Equity shareholders

49

36

157

Total comprehensive (loss) / income attributable to:

Equity shareholders

(2,084)

(199)

551

Earnings per share

- basic and diluted

4

0.4p

0.3p

1.4p

Dividend

Paid in period (£'000)

Paid in period (pence per share)

-

-

-

-

-

-

Proposed (£'000)

Proposed (pence per share)

5

-

-

-

-

-

-

 

 

 

 

 

 

 

Group Statement of Changes in Equity

 

Share Capital

Share Premium

Exchange Reserve

Retained Earnings

Available for Sale Financial Assets

Net defined benefit liability / (asset)

Total Equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance as at 1 July 2014

566

3,830

(315)

8,022

178

279

12,560

Dividends

-

-

-

-

-

-

-

Transactions with owners

-

-

-

-

-

-

-

Profit for the period

-

-

-

49

-

-

49

Other comprehensive income:

Exchange difference on translating foreign operations

-

-

(54)

-

-

-

(54)

Gain on available for sale financial assets

-

-

 

-

-

63

-

63

Re-measurement of defined benefit liability

-

-

-

-

-

(2,142)

(2,142)

Total comprehensive loss for the period

-

-

(54)

49

63

(2,142)

(2,084)

Balance as at 10 January 2015

566

3,830

(369)

8,071

241

(1,863)

10,476

 

Share Capital

Share Premium

Exchange Reserve

Retained Earnings

Available for Sale Financial Assets

Net defined benefit liability / (asset)

Total Equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance as at 1 July 2013

566

3,830

(148)

7,865

225

(329)

12,009

Dividends

-

-

-

-

-

-

Transactions with owners

-

-

-

-

-

-

-

Profit for the period

-

-

-

36

-

-

36

Other comprehensive income:

Exchange difference on translating foreign operations

 

-

 

 

-

 

 

(128)

 

-

 

-

 

 

-

 

(128)

 

(Loss) on available for sale financial assets

-

-

-

-

(53)

-

(53)

Re-measurement of defined benefit liability

-

-

-

-

-

(54)

(54)

Total comprehensive income for the period

-

-

(128)

36

(53)

(54)

(199)

Balance as at 4 January 2014

566

3,830

(276)

7,901

172

(383)

11,810

 

Share Capital

Share Premium

Exchange Reserve

Retained Earnings

Available for Sale Financial Assets

Net defined benefit liability / (asset)

Total Equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance as at 1 July 2013

566

3,830

(148)

7,865

225

(329)

12,009

Dividends

-

-

-

-

-

-

Transactions with owners

-

-

-

-

-

-

Profit for the period

-

-

-

157

-

-

157

Other comprehensive income:

Exchange difference on translating foreign operations

 

-

 

 

-

 

 

(167)

 

-

 

-

 

 

-

 

(167)

 

(Loss) on available for sale financial assets

-

-

-

-

(47)

-

(47)

Re-measurement of defined benefit liability

-

-

-

-

-

608

608

Total comprehensive income for the period

-

-

(167)

157

(47)

608

551

Balance as at 30 June 2014

566

3,830

(315)

8,022

178

279

12,560

 

 

Group Statement of Financial Position

 

As at

As at

As at

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

Notes

£'000

£'000

£'000

ASSETS

Non-current assets

Property, plant and equipment

10,676

10,660

10,406

Intangible assets

145

125

114

Deferred tax assets

887

364

275

Investments

384

316

322

Total non-current assets

12,092

11,465

11,117

Current assets

Inventories

6,403

6,384

7,065

Trade and other receivables

8,890

10,086

12,818

Cash and cash equivalents

512

494

533

Current tax receivable

1

315

232

Total current assets

15,806

17,279

20,648

Total assets

27,898

28,744

31,765

LIABILITIES

Current liabilities

Trade and other payables

12,338

13,688

16,876

Interest-bearing loans and borrowings

-

111

-

Current tax payable

21

48

54

Total current liabilities

12,359

13,847

16,930

Non-current liabilities

Post-retirement benefit obligations

7

5,002

3,021

2,212

Deferred tax liabilities

61

66

63

Total non-current liabilities

5,063

3,087

2,275

Total liabilities

17,422

16,934

19,205

Net assets

10,476

11,810

12,560

EQUITY

Share capital

566

566

566

Share premium

3,830

3,830

3,830

Other components of equity

241

172

178

Exchange reserve

(369)

(276)

(315)

Re-measurement of defined benefit liability

(1,863)

(383)

279

Retained earnings

8,071

7,901

8,022

Total equity

10,476

11,810

12,560

 

 

 

 

Group Cash Flow Statement

 

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Cash flow from operating activities

Profit / (loss) before taxation

56

(24)

140

Depreciation

503

550

1,306

Amortisation

26

36

66

Profit on disposal of property, plant and equipment

-

(84)

(78)

 

Finance income

-

-

(16)

Finance cost

108

150

278

Decrease in inventories

662

910

229

Decrease in trade and other receivables

3,315

3,045

157

(Decrease) in trade and other payables

(2,099)

(3,352)

(582)

Contributions to defined benefit plan

(200)

(197)

(413)

Current service cost of defined benefit plan

230

160

342

Cash generated from operations

2,601

1,194

1,429

Finance expense paid

(59)

(74)

(138)

Taxation received / (paid)

199

(6)

(42)

Net cash flow from operating activities

2,741

1,114

1,249

Cash flow from investing activities

Finance income received

16

Purchase of property, plant and equipment

(756)

(287)

(879)

Purchase of intangible assets

(57)

(27)

(46)

Sale of property, plant and equipment

-

251

250

Net cash flow from investing activities

(813)

(63)

(659)

Cash flow from financing activities

(Repayment) / proceeds of debt facility

(1,949)

(1,329)

(718)

Repayment of loans

-

(321)

(432)

Dividends paid

-

-

-

Net cash flow from financing activities

(1,949)

(1,650)

(1,150)

Net (decrease)/ increase in cash and cash equivalents

(21)

(599)

(560)

Cash and cash equivalents at beginning of period

533

1,093

1,093

Cash and cash equivalents at end of period

512

494

533

Cash and cash equivalents consist of:

Cash

512

494

533

Cash and cash equivalents at end of period

512

494

533

 

 

Notes to the Accounts

 

Note 1 Basis of preparation

The Group has prepared its interim results for the 28 week period ended 10 January 2015 in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) as adopted by the European Union and also in accordance with the recognition and measurement principles of IFRS issued by the International Accounting Standards Board.

 

The Directors have considered trading and cash flow forecasts prepared for the Group, and based on these, and the confirmed banking facilities, are satisfied that the Group will continue to be able to meet its liabilities as they fall due for at least one year from the date of approval of the Interim Report. On this basis, they consider it appropriate to adopt the going concern basis in the preparation of these accounts.

 

As permitted, this interim report has been prepared in accordance with the AIM rules and not in accordance with IAS34 'Interim Financial Reporting'.

 

These interim financial statements do not constitute full statutory accounts within the meaning of section 434 of the Companies Act 2006 and are unaudited. The unaudited interim financial statements were approved by the Board of Directors on 27 February 2015.

 

The consolidated financial statements are prepared under the historical cost convention as modified to include the revaluation of certain non-current assets. The accounting policies used in the interim financial statements are consistent with IFRS and those which will be adopted in the preparation of the Group's Annual Report and Financial Statements for the year ended 30 June 2015. 

 

The statutory accounts for the year ended 30 June 2014, which were prepared under IFRS, have been filed with the Registrar of Companies. These statutory accounts carried an unqualified Auditors Report and did not contain a statement under Section 498(2) or 498(3) of the Companies Act 2006.

 

Note 2 Segmental analysis

The Group operates in one reportable segment as all sales, purchasing, production and operational decisions are taken based on the overall Group operating performance. The results of this segment are as reported through the Group Statement of Comprehensive Income, Group Statement of Financial Position, Group Statement of Changes in Equity and Group Cash Flow Statement.

 

The distribution of the Group's external revenue by destination is shown below:

 

Geographical segments

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

UK

15,904

16,443

31,173

Other European Union countries

9,152

7,806

16,559

Rest of the World

919

1,183

2,301

25,975

25,432

50,033

 

In the 28 weeks ended 10 January 2015, the Group had two customers that exceeded 10% of total revenues, being 13.5% and 10.8% respectively. In the 28 weeks ended 4 January 2014, the Group had three customers that exceeded 10% of total revenues, being 15.8%, 11.4% and 10.3% respectively.

 

Exceptional items in the year ended 30 June 2014 related to the restructure of the Bideford site. This included £264,000 of accelerated depreciation on fixed asset items and £92,000 accrual for employee redundancies.

 

 

Note 3 Finance income and costs

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Finance Income

Other income

 

-

 

-

 

16

-

-

16

Finance costs

Bank loans and overdrafts

59

74

138

Net pension scheme costs

49

76

140

108

150

278

 

 

Note 4 Earnings per share

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

Basic and diluted

Profit for the period (£'000)

49

36

157

Basic weighted average number of

ordinary shares in issue during the period

11,306,416

11,306,416

11,306,416

Basic earnings per share

0.4p

0.3p

1.4p

Diluted earnings per share

0.4p

0.3p

1.4p

 

Basic earnings per share has been calculated by dividing the profit for each financial period by the weighted average number of ordinary shares in issue in the period. There is no significant difference at 10 January 2015 between the basic net earnings per share and the diluted net earnings per share.

 

The outstanding share option awards do not have a significant impact on the calculation of diluted earnings per share.

 

Adjusted earnings per share

Profit for the period (£'000)

49

36

157

(910)

Add back: Exceptional items

-

-

366

491

Notional tax charge on exceptional items

-

-

(83)

(117)

Adjusted profit before exceptional items

49

36

440

(536)

Basic weighted average number of

ordinary shares in issue during the period

11,306,416

11,306,416

11,306,416

Adjusted basic earnings per share

0.4p

0.3p

3.9p

(4.7p)

Adjusted diluted earnings per share

0.4p

0.3p

3.9p

(4.7p)

 

Adjusted earnings per share has been calculated by dividing the adjusted profit (after allowing for the notional tax charge on exceptional items) by the weighted average number of shares in issue in the period.

 

Note 5 Dividends

The Directors have not declared an interim dividend payment (2014: Interim: nil; Final: nil).

 

 

Note 6 Reconciliation of cash and cash equivalents to movement in net debt

 

28 weeks ended

28 weeks ended

12 months ended

10 Jan 2015

04 Jan 2014

30 June 2014

(unaudited)

(unaudited)

(audited)

£000's

£000's

£000's

(Decrease) / increase in cash and cash equivalents in the period

(21)

(599)

(560)

Net cash outflow / (inflow) from decrease / (increase) in borrowings

 

1,949

 

1,650

 

1,150

Change in net debt resulting from cash flows

1,928

1,051

590

Net debt at the beginning of the period

(5,077)

(5,667)

(5,667)

Net debt at the end of the period

(3,149)

(4,616)

(5,077)

 

 

Note 7 Accounting Policies

 

The accounting policies used in the interim financial statements are consistent with IFRS and those which will be adopted in the preparation of the Group's Annual Report and Financial Statements for the year ended 30 June 2015.

 

 

IAS 19 'Employee Benefits'

The effects of the application of IAS19 on the statement of financial position at 10 January 2015 are:

 

 

 

 

 

 

10 January 2015

 

 

£000's

Increase in pension and other benefit obligations

 

(2,790)

Decrease in deferred tax

 

569

Decrease in equity

 

 

(2,221)

 

 

 

 

 

The Accounting Standards require the discount rate to be based on yields on high quality (usually AA-rated) corporate bonds of appropriate currency, taking into account the term of the relevant pension scheme's liabilities. Corporate bond indices are often used as a proxy to determine the discount rate. At the reporting date, the yields on bonds of all types were significantly lower than they were at 30 June 2014. This has resulted in lower discount rates being adopted for accounting purposes compared to last year, offset by a reduction in expectations of long term inflation, and this has translated into significantly higher liabilities. The key assumptions used were:

 

 

 

As at 10 January 2015

As at 30 June 2014

Discount Rate

3.45%

4.40%

Rate of inflation (RPI)

2.95%

3.25%

Rate of inflation (CPI)

2.00%

2.30%

 

 

 Note 8 Announcement of results

These results were announced to the London Stock Exchange on 2 March 2015. The Interim Report will be sent to shareholders and is available to members of the public at the Company's Registered Office at Swallowfield House, Station Road, Wellington, Somerset, TA21 8NL.

 

Independent review report to Swallowfield plc

 

Introduction

We have been engaged by the Group to review the financial information in the half-yearly financial report for the 28 weeks ended 10 January 2015 which comprises the Group statement of comprehensive income, the Group statement of changes in equity, the Group statement of financial position, the Group cash flow statement and the related explanatory notes. We have read the other information contained in the half-yearly financial report which comprises the Chief Executive's Statement and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the Group in accordance with guidance contained in ISRE (UK and Ireland) 2410, 'Review of Interim Financial Information performed by the Independent Auditor of the Entity'. Our review work has been undertaken so that we might state to the company those matters we are required to state to them in a review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our review work, for this report, or for the conclusion we have formed.

 

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The AIM rules of the London Stock Exchange require that the accounting policies and presentation applied to the financial information in the half-yearly financial report are consistent with those which will be adopted in the annual accounts having regard to the accounting standards applicable for such accounts.

 

As disclosed in Note 1, the annual financial statements of the group are prepared in accordance with IFRS's as adopted by the European Union. The financial information in the half-yearly financial report has been prepared in accordance with the basis of preparation in Note 1.

 

Our responsibility

Our responsibility is to express to the Group a conclusion on the financial information in the half-yearly financial report based on our review.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the financial information in the half-yearly financial report for the 28 weeks ended 10 January 2015 is not prepared, in all material respects, in accordance with the basis of accounting described in Note 1.

 

 

GRANT THORNTON UK LLP

AUDITORSouthampton27 February 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UBAVRVVAUUAR
Date   Source Headline
17th Apr 20242:00 pmRNSHolding(s) in Company
2nd Apr 20245:35 pmRNSHolding(s) in Company
2nd Apr 20244:35 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim results
15th Dec 202311:34 amRNSGrant of share options
14th Dec 202310:16 amRNSGrant and cancellation of share options
12th Dec 20234:02 pmRNSResult of AGM
1st Dec 20237:00 amRNSJoint Venture Settlement: Mr Haircare Limited
31st Oct 20237:00 amRNSFinal Results
19th Sep 20234:48 pmRNSBoard Responsibilities Update
20th Jul 20237:00 amRNSTrading Update & Resolution of Legal Claim
12th Jun 202310:30 amRNSGrant of Options
6th Jun 20237:00 amRNSBoard Responsibilities
31st May 20237:00 amRNSRule 19.6(c) confirmation
26th May 20237:00 amRNSDirectorate Changes
21st Mar 20237:00 amRNSInterim Results
24th Jan 20237:00 amRNSDirectorate Change & Trading Update
19th Dec 20224:24 pmRNSResult of AGM
28th Nov 20227:00 amRNSDirectorate Change
24th Nov 202211:50 amRNSAnnual Report and Accounts & Notice of AGM
16th Nov 202211:19 amRNSHolding(s) in Company
9th Nov 20225:00 pmRNSHolding(s) in Company
8th Nov 20225:16 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 202210:16 amRNSHolding(s) in Company
3rd Aug 20223:30 pmRNSHolding(s) in Company
3rd Aug 20229:21 amRNSHolding(s) in Company
3rd Aug 20229:19 amRNSHolding(s) in Company
21st Jul 20227:00 amRNSTrading Update
14th Jul 20227:00 amRNSHolding(s) in Company
4th Jul 202211:02 amRNSHolding(s) in Company
1st Jul 202211:44 amRNSHolding(s) in Company
30th Jun 20223:53 pmRNSHolding(s) in Company
30th Jun 20221:41 pmRNSHolding(s) in Company
16th Jun 20229:03 amRNSBoard Appointment
10th Jun 202212:35 pmRNSHolding(s) in Company
10th Jun 202212:10 pmRNSDirector/PDMR Shareholding
7th Jun 20224:34 pmRNSHolding(s) in Company
7th Jun 20224:28 pmRNSHolding(s) in Company
7th Jun 202211:51 amRNSHolding(s) in Company
7th Jun 202211:48 amRNSHolding(s) in Company
7th Jun 202211:47 amRNSHolding(s) in Company
31st May 20221:57 pmRNSScheme of Arrangement Becomes Effective
31st May 20229:52 amRNSForm 8.5 (EPT/RI)
30th May 202211:54 amRNSForm 8.5 (EPT/RI)
27th May 20224:01 pmRNSCourt Sanction of Scheme and Suspension
20th May 202211:34 amRNSForm 8.5 (EPT/RI)
19th May 20224:56 pmRNSResult of General Meeting
17th May 202212:03 pmRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.